1. Pakarinen P, Toivonen J, Luukkainen T. Therapeutic Use of the LNG IDS, and Counseling. Seminars in reproductive medicine/volume 19, number 4 2001; 365–72.
2. Nilsson CG, Lahteenmaki PL, Luukkainen T. Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device. Fertil Steril 1984; 41: 52–SS.
3. Barbosa I, Bakos O, Olsson SE et al. Ovarian function during use of a levonorgestrel-releasing IUD. Contraception 1990; 42: 51–66.
5. Andersson K, Mattsson L-O, Rybo G, Stanberg E. Intrauterine release of levonorgestrel: a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 1992; 79: 963–7.
6. Faundes A, Alvarez F, Diaz J. A Latin American experience with levonorgestrel IUD. Ann Med 1993; 25: 149–53.
7. Sivin I, Alvarez F, Diaz J et al. Intrauterine contraception with qt copper and with levonorgestrel: a randomised study of the Tcu380Ag and levonorgestrel 20 ug/D devices. Contraception 1984; 30: 443–56.
8. Lei Z-W, Wu SC, Garceau RJ et al. Effects of pretreatment counseling on discontinuation rates in Chinese women given depo-meclroxyprogesterone acetate for contraception. Contraception 1996; 53: 357–61.
9. Luukkainen T, Lahteenmaki P, Toivonen J. Three years' experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: a randomized comparative study. Adv Contracept 1992; 8: 105–14.
10. Nilsson CG, Luukkainen T, Arko H. Endometrial morphology of women using a d-norgesrrel-releasing intrauterine device. Fertil Steril 1978; 29: 397–401,
11. Silverberg SG, Haukkamaa M, Arko H et al. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 1986; 3: 235–41.
12. Jones RL, Critchley HO. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 2000; 15 (suppl. 3): 162–72.
13. Rutanen E-M. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium: effect of intrauterine levonorgestrel delivery. Hum Reprod 2000; 15 (suppl. 3): 173–81.
14. Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990; 97: 690–4.
15. Milsora I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991; 164: 879–83.
16. Tang GW, Loa SS. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Contraception 1995; 51: 231–5.
17. Kittelsen N, Istre ОA. A randomized study comparing levonorgestrel intrauterine system (LNG IUS) and transcervical resection of the endometrium (TRCE) in the treatment of menorrhagia: preliminary results. Gynaecol Endoscopy 1998; 7: 61–5.
18. Hurskainen R, Teperi J, Rissanen P et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomized trial. Lancet 2001; 357: 273–7.
19. Lahteenmaki P, Haukkamaa M, Puolakka J et al. Open randomized study of use of levonorgestrel intrauterine system as alternative to hysterectomy. BMJ 1998; 316: 112–6.
20. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen-AQ2 releasing intrauterine systems versus either placebo or any AQ2 other medication for heavy menstrual bleeding. Cochrane Database Syst Rev 2000; 2: CD002126.
21. Stewart A, Cummins C, Gold L et al. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001; 108: 74–86.
22. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss: a population study. Acta Obstet Gynecol Scand 1966; 45: 320–51.
23. Cohen BJ, Gibor Y Anemia and menstrual blood loss. Obstet Gynecol Surv 1980; 35: 597–618.
24. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and Ш copper-releasing (NovaT) IUDs during five years of use: a randomized comparative trial. Contraception 1994; 49: 56–72.
25. Faundes A, Alvarez F, Brache V, Tejada AS. The role of the levonorgestrel IUD in the prevention and treatment of iron deficiency anemia during fertility regulation. Int J Gynecol Obstet 1988; 26: 429–33.
26. Luukkainen T, Allonen H, Haukkamaa M et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Contraception 1987; 36: 169–79.
27. Barrington JW, Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 1997; 104: 614–6.
28. Jones RL, Critchley HO. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 2000; 15 (suppl. 3): 162–72.
29. Scholten PC. The Levonorgestrel IUD: Clinical Performance and Impact on Menstruation [dissertation]. Utrecht, The Netherlands: 1989.
30. Pike MC, Ross RK. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids 2000; 65: 659–64.
31. Schairer C, Lubin J, Troisi R et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000; 283: 485–91.
32. Raudaskoski TH, Lahti El, Kauppila AJ et al. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial response. Am J Obstet Gynecol 1995; 172: 114–9.
33. Vercellini P, Aimi G, Panazza SJ et al. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril 1999; 72: 505–8.
34. Fedele L, Bianchi S, Zanconato G et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001; 75: 485–8.
35. Fedele L, Bianchi S, Raffaelli R et al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997; 68: 426–9.
36. Fong YF, Singh K. Medical treatment of a grossly enlarged ade-rb nomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception 1999; 60: 173–5.

М.А.Тарасова, В.А.Григорьева

НИИ акушерства и гинекологии им. Д.О.Отта 
(дир. – акад. РАМН Э.К.Айпамазян) РАМН, Санкт-Петербург